AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,807 | -61.5% | 3,064 | -52.1% | 0.00% | -50.0% |
| Q2 2023 | $61,855 | +150765.9% | 6,390 | +69.9% | 0.00% | +100.0% |
| Q1 2023 | $41 | -69.9% | 3,761 | -88.1% | 0.00% | -83.3% |
| Q4 2022 | $136 | -99.7% | 31,512 | +356.5% | 0.01% | +500.0% |
| Q3 2022 | $52,000 | -69.6% | 6,903 | -59.5% | 0.00% | -75.0% |
| Q2 2022 | $171,000 | -1.7% | 17,053 | +21.0% | 0.00% | +100.0% |
| Q1 2022 | $174,000 | -33.8% | 14,094 | +22.3% | 0.00% | -60.0% |
| Q4 2021 | $263,000 | +270.4% | 11,521 | +258.6% | 0.01% | +150.0% |
| Q3 2021 | $71,000 | -38.8% | 3,213 | -64.1% | 0.00% | -33.3% |
| Q2 2021 | $116,000 | +452.4% | 8,942 | +449.3% | 0.00% | – |
| Q1 2021 | $21,000 | -44.7% | 1,628 | -41.4% | 0.00% | -100.0% |
| Q4 2020 | $38,000 | -29.6% | 2,780 | -24.0% | 0.00% | 0.0% |
| Q3 2020 | $54,000 | +145.5% | 3,657 | +165.8% | 0.00% | 0.0% |
| Q2 2020 | $22,000 | -74.7% | 1,376 | -68.3% | 0.00% | -85.7% |
| Q4 2019 | $87,000 | +93.3% | 4,339 | -48.2% | 0.01% | +133.3% |
| Q3 2019 | $45,000 | +542.9% | 8,382 | +630.1% | 0.00% | – |
| Q2 2019 | $7,000 | -12.5% | 1,148 | -11.7% | 0.00% | – |
| Q1 2019 | $8,000 | -27.3% | 1,300 | -18.8% | 0.00% | -100.0% |
| Q4 2018 | $11,000 | +266.7% | 1,600 | +300.0% | 0.00% | – |
| Q3 2018 | $3,000 | -83.3% | 400 | -87.8% | 0.00% | -100.0% |
| Q1 2018 | $18,000 | -28.0% | 3,273 | -24.9% | 0.00% | -33.3% |
| Q4 2017 | $25,000 | +25.0% | 4,359 | +74.4% | 0.00% | +50.0% |
| Q3 2017 | $20,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $20,000 | +17.6% | 2,500 | +8.7% | 0.00% | 0.0% |
| Q1 2017 | $17,000 | +325.0% | 2,300 | +130.0% | 0.00% | – |
| Q2 2016 | $4,000 | +300.0% | 1,000 | +233.3% | 0.00% | – |
| Q1 2016 | $1,000 | -94.7% | 300 | -96.1% | 0.00% | -100.0% |
| Q4 2015 | $19,000 | +850.0% | 7,767 | +1194.5% | 0.00% | – |
| Q3 2015 | $2,000 | -85.7% | 600 | -83.8% | 0.00% | -100.0% |
| Q2 2015 | $14,000 | -22.2% | 3,700 | +15.6% | 0.00% | -50.0% |
| Q1 2015 | $18,000 | +63.6% | 3,200 | +5.0% | 0.00% | +100.0% |
| Q4 2014 | $11,000 | +120.0% | 3,048 | +90.5% | 0.00% | 0.0% |
| Q3 2014 | $5,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |